Literature DB >> 2857104

Long term treatment of acromegaly with a long acting analogue of somatostatin.

L J Ch'ng, L M Sandler, M E Kraenzlin, J M Burrin, G F Joplin, S R Bloom.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2857104      PMCID： PMC1417552          DOI： 10.1136/bmj.290.6464.284-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  5 in total

1.  Growth hormone hypersecretion and acromegaly.

Authors:  W H Daughaday; P E Cryer
Journal:  Hosp Pract       Date:  1978-08

2.  Acromegaly and cardiovascular disorders. A prospective study.

Authors:  W L McGuffin; B M Sherman; F Roth; P Gorden; C R Kahn; W C Roberts; P L Frommer
Journal:  Ann Intern Med       Date:  1974-07       Impact factor: 25.391

3.  SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action.

Authors:  W Bauer; U Briner; W Doepfner; R Haller; R Huguenin; P Marbach; T J Petcher
Journal:  Life Sci       Date:  1982-09-13       Impact factor: 5.037

4.  Conventional pituitary irradiation in acromegaly. Effect on growth hormone and TSH secretion.

Authors:  B A Lamberg; V Kivikangas; J Vartianen; C Raitta; R Pelkonen
Journal:  Acta Endocrinol (Copenh)       Date:  1976-06

5.  Growth hormone release inhibiting hormone in acromegaly.

Authors:  G M Besser; C H Mortimer; D Carr; A V Schally; D H Coy; D Evered; A J Kastin; W M Tunbridge; M O Thorner; R Hall
Journal:  Br Med J       Date:  1974-03-02
  5 in total
  11 in total

1.  Endocrine effects of combined somatostatin analog and bromocriptine therapy in women with advanced breast cancer.

Authors:  A Manni; A E Boucher; L M Demers; H A Harvey; A Lipton; M A Simmonds; M Bartholomew
Journal:  Breast Cancer Res Treat       Date:  1989-12       Impact factor: 4.872

2.  Effect of a new long-acting somatostatin analogue (SMS 201-995) on glycemic and hormonal response to a mixed meal in acromegalic patients.

Authors:  R Candrina; A Gussago; G Giustina
Journal:  J Endocrinol Invest       Date:  1988-01       Impact factor: 4.256

3.  Effect of high dose somatostatin analogue on growth hormone concentrations in acromegaly.

Authors:  L M Sandler; J M Burrin; G F Joplin; S R Bloom
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-12

Review 4.  Somatostatin.

Authors:  S R Bloom; J M Polak
Journal:  Br Med J (Clin Res Ed)       Date:  1987-08-01

5.  Effect of a new long-acting somatostatin analogue (SMS 201-995) on glycemic and hormonal profiles in insulin-treated type II diabetic patients.

Authors:  R Candrina; G Giustina
Journal:  J Endocrinol Invest       Date:  1988 Jul-Aug       Impact factor: 4.256

6.  Acromegalic cardiopathy improves after treatment with increasing doses of octreotide.

Authors:  J L Pereira; M J Rodriguez-Puras; A Leal-Cerro; A Martinez; P P Garcia-Luna; I Gavilan; A Pumar; R Astorga
Journal:  J Endocrinol Invest       Date:  1991-01       Impact factor: 4.256

Review 7.  Current status and future opportunities for controlling acromegaly.

Authors:  Shlomo Melmed; Mary Lee Vance; Ariel L Barkan; Bengt-Ake Bengtsson; David Kleinberg; Anne Klibanski; Peter J Trainer
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

Review 8.  Acromegaly. Recognition and treatment.

Authors:  C A Jaffe; A L Barkan
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

Review 9.  Octreotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in conditions associated with excessive peptide secretion.

Authors:  P E Battershill; S P Clissold
Journal:  Drugs       Date:  1989-11       Impact factor: 9.546

10.  Glucose tolerance during long term treatment with a somatostatin analogue.

Authors:  L Verschoor; S W Lamberts; P Uitterlinden; E Del Pozo
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.